Collagen has become a buzzword for youthfulness and glow but does it really live up to its reputation? TODAY contributor and dermatologist Dr. Michelle Henry joins Studio 1A to explain whether collagen is overhyped and break down the benefits of the ...
Spring allergies are in full bloom but there are ways to prevent common symptoms. Dr. Mikhail Varshavski, board-certified family medical physician, joins TODAY with ways to identify symptoms rooted in allergies, explore treatment options and more.
The Food and Drug Administration on Wednesday approved Eli Lilly's new GLP-1 daily pill called Foundayo. It's a new option for the millions looking to try weight loss drugs without having to use a needle and it's set to hit the market next week. It . ...
The suit, filed Thursday, is part of a growing trend of similar cases across the South. The plaintiffs argue that midwives are crucial to address maternity care deserts.
Hib once killed 1,000 children a year, permanently disabling many more. Doctors who've never seen the disease say the comeback is changing the way they practice medicine.
The daily pill, called Foundayo, follows the approval of Novo Nordisk's Wegovy pill in recent months. The lowest dose is expected to cost about $149 a month out of pocket.
According to the CDC, 1 in 4 adults have a seasonal allergy, so Dr. Jen Caudle, family physician and associate professor at Rowan University, joins TODAY to share her spring allergy survival guide. Tips include wearing sunglasses outside, checking .. ...
After a string of denials for rare disease treatment candidates, the FDA last week greenlit a drug for Hunter syndrome, a progressive illness affecting about 500 Americans.
Last summer in our series "The Cost of Denial," NBC News' Erin McLaughlin reported on Eric Tennant who was seeking a treatment for the bile duct cancer he had, hoping it would prolong his life. Insurance denied coverage at first, and once it was ...